The cerebroplacental ratio is a Doppler ultrasound measurement that compares blood flow in the fetal brain and the umbilical cord. A low CPR suggests that the fetus may be redirecting blood flow to the brain due to placental dysfunction, an indication that the baby might be under stress despite appearing normally grown.
The CEPRA trial (Cerebroplacental Ratio-based Management) is the first randomized study to evaluate whether using this ratio to guide clinical decisions could improve outcomes in pregnancies where mothers feel reduced fetal movement, but the fetus is not underweight.
The study enrolled 1,815 pregnant women across 23 hospitals—22 in the Netherlands and one in Australia—between July 2020 and September 2024. All participants were carrying singleton pregnancies in a cephalic presentation at term and had reported reduced fetal movement. Women were eligible only if their estimated fetal weight was above the 10th percentile and there was no immediate reason for inducing labor.
Hospitals were randomly assigned to two groups: one where CPR results were disclosed and used to guide clinical management (revealed group), and the other where care proceeded according to usual hospital protocols without disclosing CPR values (concealed group). In the revealed group, women with a CPR below 1.1 were advised expedited delivery, while those with higher ratios continued with routine monitoring.
The study revealed the following findings:
- A total of 1,684 women were in the modified intention-to-treat analysis.
- Adverse perinatal outcomes occurred in 12% of women who received CPR-based management.
- In the standard care group, adverse outcomes were in 15% of women; corresponding to a relative risk reduction of 24% in the CPR-guided group.
- There were no stillbirths in either group.
- One neonatal death occurred in each group.
- The adverse outcomes included neonatal mortality, low five-minute Apgar scores, low umbilical artery pH, emergency births due to fetal distress, and severe neonatal morbidity.
- Serious adverse events were slightly more common in the standard care group.
- None of the serious adverse events were related to the study protocol.
The research offers a new perspective on managing pregnancies where reduced fetal movements are reported but fetal growth appears normal. “These findings suggest that CPR can help distinguish between cases that require early intervention and those that do not,” said co-author Dr. Sanne Gordijn. “This ensures that both mother and baby receive the care best suited to their situation.”
The authors concluded, "The study reinforces the value of Doppler-based screening in identifying hidden risks in term pregnancies. It provides a foundation for updating clinical guidelines in managing reduced fetal movements in non-SGA fetuses."
Reference:
Lens, L. A., Posthuma, S., Damhuis, S. E., Burger, R. J., Groen, H., Duijnhoven, R. G., Kumar, S., Heazell, A. E. P., Khalil, A., Ganzevoort, W., & Gordijn, S. J. (2025). Cerebroplacental ratio-based management versus care as usual in non-small-for-gestational-age fetuses at term with maternal perceived reduced fetal movements (CEPRA): A multicentre, cluster-randomised controlled trial. The Lancet Obstetrics, Gynaecology, & Women's Health, 100002. https://doi.org/10.1016/j.lanogw.2025.100002
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.